ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Japan Medical Dynamic Marketing's annualizedNet Income for the quarter that ended in Mar. 2026 was €-0.5 Mil.
Japan Medical Dynamic Marketing's average Total Assets over the quarter that ended in Mar. 2026 was €191.7 Mil. Therefore, Japan Medical Dynamic Marketing's annualized ROA % for the quarter that ended in Mar. 2026 was -0.27%.
FRA:JMD'
s ROA % Range Over the Past 10 Years
Min: -1.42 Med: 6.04 Max: 8.95
Current: 0.78
During the past 13 years, Japan Medical Dynamic Marketing's highest ROA % was 8.95%. The lowest was -1.42%. And the median was 6.04%.
FRA:JMD's ROA % is ranked better than 50.64% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs FRA:JMD: 0.78
Japan Medical Dynamic Marketing (FRA:JMD) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Japan Medical Dynamic Marketing ROA % Related Terms
Japan Medical Dynamic Marketing ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Japan Medical Dynamic Marketing's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Medical Dynamic Marketing ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's ROA % distribution charts can be found below:
* The bar in red indicates where Japan Medical Dynamic Marketing's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Japan Medical Dynamic Marketing (FRA:JMD) has a ROA % of -0.27% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Japan Medical Dynamic Marketing and its competitors. According to the industry distribution chart, Japan Medical Dynamic Marketing ranks #423 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 49.4%.
Is Japan Medical Dynamic Marketing's ROA % too high?
Japan Medical Dynamic Marketing's current ROA % is -0.27%. Based on the distribution chart, Japan Medical Dynamic Marketing ranks #423 out of 857 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Medical Dynamic Marketing ranks #423 out of 857 companies for ROA %. This puts Japan Medical Dynamic Marketing in the upper half of its industry. The industry median ROA % is 0.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Japan Medical Dynamic Marketing and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Medical Dynamic Marketing's current ROA % is -0.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (FRA:JMD) has a current ROA % of -0.27%. The stock's GF Value™ is €3.40, compared to a current price of €4.88 — trading 43.5% above its estimated fair value. The current ROA % is -0.27%. Japan Medical Dynamic Marketing's overall GF Score™ is 78/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (FRA:JMD), the current ROA % is -0.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Medical Dynamic Marketing (FRA:JMD) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued.
The current stock price of €4.88 is trading 43.5% above its estimated GF Value™ of €3.40.
Key valuation signals for FRA:JMD:
ROA %: -0.27%
GF Value™: €3.40 vs. price of €4.88 (43.5% above fair value)
No single metric tells the full story. See the FRA:JMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Medical Dynamic Marketing Business Description
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
78GF Score
Get the complete analysis for FRA:JMD
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:JMD has been successfully added to your 
